Table 1.
Characteristic | Value |
---|---|
Demographic | |
Age, mean (range) (years) | 46 (37–61) |
Female | 7 (64) |
Race | |
Black, non-Hispanic | 4 |
White, non-Hispanic | 5 |
Hispanic | 2 |
Substance use history | |
Injection drug use | 11 (100) |
Polysubstance drug use | 11 (100) |
Psychiatric history | 11 (100) |
Prescribed psychotropic medications pre-study | 11 (100) |
Depression | 9 (82) |
Anxiety | 6 (55) |
Panic disorder | 1 (9) |
Schizoaffective disorder | 1 (9) |
Post-traumatic stress disorder | 1 (9) |
HCV-related clinical values | |
Biopsy stage (Batts and Ludwig staging system) | |
Stage 1 | 1 (9) |
Stage1–2 or 2 | 5 (45) |
Stage 3 | 1 (9) |
Stage 3–4 or 4 | 4 (36) |
High HCV RNA (>400,000 IU/ml) | 9 (82) |
HIV-related clinical values | |
On HAART | 10 (91) |
CD4+ cell count, mean (range) (cells/μL) | 498 (210–868) |
Undetectable HIV RNA (<75 copies/ml) | 9 (82) |
Note: Data are no. (%) of participants, except where noted.